ACTRAPID PENFILL human insulin (rys) 100IU/mL injection multidose cartridge Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

actrapid penfill human insulin (rys) 100iu/ml injection multidose cartridge

novo nordisk pharmaceuticals pty ltd - insulin, quantity: 100 iu/ml - injection, solution - excipient ingredients: metacresol; sodium hydroxide; glycerol; hydrochloric acid; water for injections; zinc chloride - the treatment of insulin-requiring diabetes.

NOVOMIX 30 FLEXPEN 3mL 30% soluble insulin aspart (rys) and 70% insulin aspart (rys) crystallised with protamine 300U/3mL injection syringe Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

novomix 30 flexpen 3ml 30% soluble insulin aspart (rys) and 70% insulin aspart (rys) crystallised with protamine 300u/3ml injection syringe

novo nordisk pharmaceuticals pty ltd - insulin aspart, quantity: 100 u/ml - injection, suspension - excipient ingredients: hydrochloric acid; zinc; metacresol; water for injections; glycerol; sodium chloride; protamine sulfate; sodium hydroxide; dibasic sodium phosphate dihydrate; phenol - treatment of diabetes mellitus.

NOVOMIX 30 PENFILL 3mL 30% soluble insulin aspart (rys) and 70% insulin aspart (rys) crystallised with protamine 300U/3mL injection cartridge Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

novomix 30 penfill 3ml 30% soluble insulin aspart (rys) and 70% insulin aspart (rys) crystallised with protamine 300u/3ml injection cartridge

novo nordisk pharmaceuticals pty ltd - insulin aspart, quantity: 100 u/ml - injection, suspension - excipient ingredients: zinc; dibasic sodium phosphate dihydrate; protamine sulfate; metacresol; sodium chloride; sodium hydroxide; glycerol; phenol; hydrochloric acid; water for injections - treatment of diabetes mellitus.

NOVORAPID FLEXPEN insulin aspart (rys) 300U/3mL injection multidose cartridge Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

novorapid flexpen insulin aspart (rys) 300u/3ml injection multidose cartridge

novo nordisk pharmaceuticals pty ltd - insulin aspart, quantity: 100 u/ml - injection, solution - excipient ingredients: phenol; sodium chloride; sodium hydroxide; water for injections; hydrochloric acid; zinc; metacresol; dibasic sodium phosphate dihydrate; glycerol - treatment of diabetes mellitus.

NOVORAPID PENFILL insulin aspart (rys) 300U/3mL injection cartridge Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

novorapid penfill insulin aspart (rys) 300u/3ml injection cartridge

novo nordisk pharmaceuticals pty ltd - insulin aspart, quantity: 100 u/ml - injection, solution - excipient ingredients: phenol; zinc; dibasic sodium phosphate dihydrate; sodium hydroxide; glycerol; metacresol; sodium chloride; water for injections; hydrochloric acid - treatment of diabetes mellitus.

NOVORAPID insulin aspart (rys) 100U/mL injection multidose vial Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

novorapid insulin aspart (rys) 100u/ml injection multidose vial

novo nordisk pharmaceuticals pty ltd - insulin aspart, quantity: 100 u/ml - injection, solution - excipient ingredients: water for injections; metacresol; glycerol; sodium chloride; dibasic sodium phosphate dihydrate; hydrochloric acid; sodium hydroxide; zinc; phenol - treatment of diabetes mellitus.

RYZODEG 70/30 PENFILL 70% insulin degludec (rys) / 30% insulin aspart (rys) 100 U/mL solution for injection cartridge Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

ryzodeg 70/30 penfill 70% insulin degludec (rys) / 30% insulin aspart (rys) 100 u/ml solution for injection cartridge

novo nordisk pharmaceuticals pty ltd - insulin aspart, quantity: 180 nmol/ml; insulin degludec, quantity: 420 nmol/ml - injection, solution - excipient ingredients: zinc acetate; phenol; hydrochloric acid; sodium chloride; metacresol; water for injections; sodium hydroxide; glycerol - for use in diabetes mellitus in patients aged 6 years and older.

RYZODEG 70/30 FLEXTOUCH 70% insulin degludec (rys) / 30% insulin aspart (rys) 100 U/mL solution for injection cartridge Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

ryzodeg 70/30 flextouch 70% insulin degludec (rys) / 30% insulin aspart (rys) 100 u/ml solution for injection cartridge

novo nordisk pharmaceuticals pty ltd - insulin degludec, quantity: 420 nmol/ml; insulin aspart, quantity: 180 nmol/ml - injection, solution - excipient ingredients: water for injections; metacresol; phenol; zinc acetate; sodium hydroxide; glycerol; hydrochloric acid; sodium chloride - for use in diabetes mellitus in patients aged 6 years and older.

TRUVELOG insulin aspart 100 units/mL solution for injection vial Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

truvelog insulin aspart 100 units/ml solution for injection vial

sanofi-aventis australia pty ltd - insulin aspart, quantity: 3.5 mg/ml - injection, solution - excipient ingredients: metacresol; phenol; polysorbate 20; sodium hydroxide; hydrochloric acid; water for injections; zinc chloride; sodium chloride - for the treatment of diabetes mellitus

Truvelog New Zealand - Ingliż - Medsafe (Medicines Safety Authority)

truvelog

pharmacy retailing (nz) ltd t/a healthcare logistics - insulin aspart 100 u/ml (3.5 mg/ml) - solution for injection - 100 u/ml - active: insulin aspart 100 u/ml (3.5 mg/ml) excipient: hydrochloric acid metacresol phenol polysorbate 20 sodium chloride sodium hydroxide water for injection zinc chloride - treatment of diabetes mellitus